US equities |
NVDA $178.04 ▼-4.61% AMD $486.59 ▲+8.36% MU $714.26 ▲+3.52% SPCX $141.77 ▲+5.59% AMZN $272.44 ▲+5.07% SNDK $880.57 ▲+5.45% TSLA $376.74 ▲+5.17% GOOGL $292.80 ▲+2.82%
FinancialContent

Knight Therapeutics Inc (TSX:GUD)

11.47 +0.05 (+0.44%)
Delayed Quote Updated: 9:47 AM EST, Nov 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Knight Therapeutics Inc

News headline image
What Knight Therapeutics (GUD) Said on Its Q3 Earnings Call ↗
Knight Therapeutics (TSE:GUD) raised its 2026 revenue and adjusted EBITDA outlook after reporting third-quarter growth driven by its promoted products and launches in Canada and Latin America. The... 
Via MarketBeat
Topics Earnings
News headline image
Knight Therapeutics Q2 Earnings Call Highlights ↗
Knight Therapeutics (TSE:GUD) reported record results for the first six months of 2026 and raised its full-year outlook, citing growth in its promoted products, contributions from recent launches and... 
Via MarketBeat
Topics Earnings
InvestorNewsBreaks – Knight Therapeutics Inc. (TSX: GUD) Repays Credit Facility Used to Fund Paladin Acquisition
Via Investor Brand Network
News headline image
2 Canadian Stocks Supercharged to Surge in 2026 ↗
Two TSX names just posted record results at their annual meetings, and I think both are built to run higher this year. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Top Canadian Pharmaceutical Stocks In April 2023 ↗
When investors discuss striking it rich in the stock market, they often discuss a few industries. One of them being technology and the other being pharmaceutical stocks. 
Via Talk Markets